Neoadjuvant Nivolumab Plus Chemotherapy Followed by Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV+ Oropharyngeal Cancer: OPTIMA II Phase 2 Open-Label Nonrandomized Clinical Trial
JAMA Oncol 2024 Jun 06;[EPub Ahead of Print], AJ Rosenberg, N Agrawal, A Juloori, J Cursio, Z Gooi, E Blair, J Chin, D Ginat, O Pasternak-Wise, R Hasina, A Starus, FS Jones, E Izumchenko, E MacCracken, R Wolk, N Cipriani, MW Lingen, AT Pearson, TY Seiwert, DJ Haraf, EE VokesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.